This present invention relates to sustained release pharmaceutical composition of Agomelatine. The invention is particularly suitable for once-a-day solid oral pharmaceutical dosage forms which release therapeutically effective amount of the active ingredient over an extended time period. Further, the present invention relates to process for the preparation of the same.